ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies: D-Vd or D-Rd in R/R MM Patients With Early or Late Relapse After Initial Therapy
By
ASCO 2022 Conference Coverage
FEATURING
Andrew Spencer
By
ASCO 2022 Conference Coverage
FEATURING
Andrew Spencer
Login to view comments.
Click here to Login
Myeloma